Evaluation of different types of adjuvants in a malaria transmission-blocking vaccine

In conclusion, CpG may confer enhanced efficacy for the rPSOP25 vaccine, as evidenced by the ability of the elicited antisera to induce protective immune responses and improved transmission-blocking activity.PMID:38460299 | DOI:10.1016/j.intimp.2024.111817

Source: International Immunopharmacology - March 9, 2024 Category: Allergy & Immunology Authors: Xinxin Yu Hui Min Shijie Yao Guixiang Yao Di Zhang Biying Zhang Muyan Chen Fei Liu Liwang Cui Li Zheng Yaming Cao Source Type: research